4,5,6,7-tetrahydroisoxazolo(4,5-c)pyridin-3-ol has been researched along with Myelodysplastic Syndromes in 1 studies
4,5,6,7-tetrahydroisoxazolo(4,5-c)pyridin-3-ol: inhibitor of GABA uptake systems; RN given refers to parent cpd
Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hereditary thrombocytopenia is a heterogeneous group of congenital disorders with a wide range of symptoms depending on the severity of platelet dysfunction or thrombocytopenia." | 1.72 | Novel THPO variant in hereditary thrombocytopenia: A potential candidate variant for predisposition to myeloid neoplasm. ( Jeong, DJ; Kim, MJ; Kwon, S; Kwon, SR; Lee, DS; Lee, YE; Park, JH; Yun, J, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kwon, SR | 1 |
| Kim, MJ | 1 |
| Lee, YE | 1 |
| Yun, J | 1 |
| Jeong, DJ | 1 |
| Park, JH | 1 |
| Kwon, S | 1 |
| Lee, DS | 1 |
1 other study available for 4,5,6,7-tetrahydroisoxazolo(4,5-c)pyridin-3-ol and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Novel THPO variant in hereditary thrombocytopenia: A potential candidate variant for predisposition to myeloid neoplasm.
Topics: Disease Susceptibility; Humans; Myelodysplastic Syndromes; Myeloproliferative Disorders; Neoplasms; | 2022 |